116 related articles for article (PubMed ID: 21697304)
1. Pilot study of FPPRGD2 for imaging α(v)β(3) integrin--how integral are integrins?
Choyke PL
Radiology; 2011 Jul; 260(1):1-2. PubMed ID: 21697304
[TBL] [Abstract][Full Text] [Related]
2. Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.
Mittra ES; Goris ML; Iagaru AH; Kardan A; Burton L; Berganos R; Chang E; Liu S; Shen B; Chin FT; Chen X; Gambhir SS
Radiology; 2011 Jul; 260(1):182-91. PubMed ID: 21502381
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Iagaru A; Mosci C; Shen B; Chin FT; Mittra E; Telli ML; Gambhir SS
Radiology; 2014 Nov; 273(2):549-59. PubMed ID: 25033190
[TBL] [Abstract][Full Text] [Related]
4. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
[TBL] [Abstract][Full Text] [Related]
5. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
6. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
[TBL] [Abstract][Full Text] [Related]
7. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Li ZB; Chen K; Chen X
Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838
[TBL] [Abstract][Full Text] [Related]
8. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
9. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
[TBL] [Abstract][Full Text] [Related]
10. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.
Dijkgraaf I; Terry SY; McBride WJ; Goldenberg DM; Laverman P; Franssen GM; Oyen WJ; Boerman OC
Contrast Media Mol Imaging; 2013; 8(3):238-45. PubMed ID: 23606427
[TBL] [Abstract][Full Text] [Related]
11. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X
J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267
[TBL] [Abstract][Full Text] [Related]
12. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
[TBL] [Abstract][Full Text] [Related]
13. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurements.
Minamimoto R; Jamali M; Barkhodari A; Mosci C; Mittra E; Shen B; Chin F; Gambhir SS; Iagaru A
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1850-8. PubMed ID: 26062933
[TBL] [Abstract][Full Text] [Related]
15. 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.
Liu S; Liu Z; Chen K; Yan Y; Watzlowik P; Wester HJ; Chin FT; Chen X
Mol Imaging Biol; 2010 Oct; 12(5):530-8. PubMed ID: 19949981
[TBL] [Abstract][Full Text] [Related]
16. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
[TBL] [Abstract][Full Text] [Related]
17. Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide.
Chen X; Tohme M; Park R; Hou Y; Bading JR; Conti PS
Mol Imaging; 2004 Apr; 3(2):96-104. PubMed ID: 15296674
[TBL] [Abstract][Full Text] [Related]
18. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
Lee YS; Jeong JM; Kim HW; Chang YS; Kim YJ; Hong MK; Rai GB; Chi DY; Kang WJ; Kang JH; Lee DS; Chung JK; Lee MC; Suh YG
Nucl Med Biol; 2006 Jul; 33(5):677-83. PubMed ID: 16843843
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang X; Xiong Z; Wu Y; Cai W; Tseng JR; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):113-21. PubMed ID: 16391195
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers.
Liu Z; Liu S; Wang F; Liu S; Chen X
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1296-307. PubMed ID: 19296102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]